NCT04885907View on ClinicalTrials.gov

Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

August 30, 2021

Conditions
Vaccine Response ImpairedImmune SuppressionCovid19
Interventions
BIOLOGICAL

mRNA-1273 vaccine

COVID vaccine 3rd dose

OTHER

Normal Saline Placebo

Normal Saline Placebo

Trial Locations (2)

M5G 2N2

University Health Network, Toronto General Hospital, Toronto

M5G2N2

University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER